Date | Title | Description |
30.08.2024 | Cambio's Leap Forward: MDR Certification and Market Expansion | Cambio, a prominent player in the e-health sector, has recently achieved a significant milestone. The company’s electronic health record (EHR) system, Cosmic, along with its clinical decision support (CDS) solution, has received MDR certifi... |
30.08.2024 | Cambio receives MDR certification for EHR-system and clinical decision support | Cambio receives MDR certification for EHR-system and clinical decision support
Fri, Aug 30, 2024 12:10 CET Report this content
Cambio's electronic health record system Cosmic and their solution for clinical decision support (CDS) have now b... |
30.08.2024 | Cambio Interim Report Q2 2024 | Cambio Interim Report Q2 2024
Fri, Aug 30, 2024 09:00 CET Report this content
The previous quarter held a lot of progress for us at Cambio. Getting the confidence from Åland to be a part of their coming journey in healthcare with delivering... |
10.06.2024 | Peter Gille appointed acting CEO of MSAB | Peter Gille appointed acting CEO of MSAB
Mon, Jun 10, 2024 20:00 CET Report this content
The board of MSAB has appointed the current chairman, Peter Gille, as acting CEO with immediate effect. Peter Heuman is simultaneously leaving his posi... |
04.06.2024 | Karolinska university hospital chooses Cambio Platform | Karolinska university hospital chooses Cambio Platform
Tue, Jun 04, 2024 13:15 CET Report this content
As a result of a broad procurement Cambio has been selected by Karolinska University Hospital as one supplier in the hospital's investmen... |
31.05.2024 | Sanolium interim report Q1 Jan-Mar 2024 | Sanolium interim report Q1 Jan-Mar 2024
Fri, May 31, 2024 09:00 CET Report this content
Today Sanolium releases the interim report for the first quarter this year
“We have continued developing the company in line with our strategic directio... |
21.05.2024 | Cambio awarded the contract to deliver the main electronic health record system Cambio COSMIC to Åland | Cambio awarded the contract to deliver the main electronic health record system Cambio COSMIC to Åland
Tue, May 21, 2024 13:30 CET Report this content
Cambio, the leading player in eHealth in the Nordic region, has won the procurement for a... |
30.04.2024 | Sanolium AB today released its annual report and sustainability report for 2023 | Sanolium AB today released its annual report and sustainability report for 2023
Tue, Apr 30, 2024 09:00 CET Report this content
Sanolium AB, owner of Cambio Healthcare Systems AB and its subsidiaries, today releases its annual report for 20... |
25.04.2024 | Sanolium publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm | Sanolium publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm
Thu, Apr 25, 2024 15:29 CET Report this content
Sanolium AB (publ) (the "Company" or "Sanolium") has issued a senior secured bon... |
22.03.2024 | Cambio strengthens the team and recruits Chief Customer Delivery Officer | Cambio strengthens the team and recruits Chief Customer Delivery Officer
Fri, Mar 22, 2024 11:30 CET Report this content
Starting May 20, Nicklas Hjalmarsson will be the new Chief Customer Delivery Officer at Cambio. With his long experienc... |
15.03.2024 | Sanolium announces that the condition for the early redemption of its outstanding 2019/2024 bonds has been satisfied | Sanolium announces that the condition for the early redemption of its outstanding 2019/2024 bonds has been satisfied
Fri, Mar 15, 2024 17:00 CET Report this content
On 29 February 2024, Sanolium AB (publ) (the "Company" or "S... |
11.03.2024 | Sanolium successfully announces results from the tender offer | Sanolium successfully announces results from the tender offer
Mon, Mar 11, 2024 09:00 CET Report this content
NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS OR TO A... |
07.03.2024 | Sanolium successfully issued new senior secured bonds of SEK 1,000m | Sanolium successfully issued new senior secured bonds of SEK 1,000m
Thu, Mar 07, 2024 17:30 CET Report this content
NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS O... |
29.02.2024 | Cambio Year End Report Q4 2023 | Cambio Year End Report Q4 2023
Thu, Feb 29, 2024 08:00 CET Report this content
We had a strong fourth quarter, characterized by solid profitable growth and important customer wins. Customer Group KGC (Kundgrupp Cosmic), which consists of ei... |
29.02.2024 | Sanolium contemplates issuance of new senior secured bonds, announces a conditional tender offer for its outstanding 2019/2024 bonds and gives a conditional call notice of early redemption | Sanolium contemplates issuance of new senior secured bonds, announces a conditional tender offer for its outstanding 2019/2024 bonds and gives a conditional call notice of early redemption
Thu, Feb 29, 2024 08:00 CET Report this content
NOT... |
30.11.2023 | KGC regions extends agreement regarding support and maintenance of the electronic health record system Cambio COSMIC | KGC regions extends agreement regarding support and maintenance of the electronic health record system Cambio COSMIC
Thu, Nov 30, 2023 08:30 CET Report this content
The agreement between the regions within Client group Cosmic (KGC) and Camb... |
30.11.2023 | Interim report Q3 2023 | Interim report Q3 2023
Thu, Nov 30, 2023 09:00 CET Report this content
Growing demand for our solutions reflects the need for increased digitalization in health- and social care. The Nordic regions and municipalities need to invest more in ... |
05.10.2023 | Cecilia Täkte appointed as Chief Commercial Officer at Cambio | Cecilia Täkte appointed as Chief Commercial Officer at Cambio
Thu, Oct 05, 2023 08:00 CET Report this content
Cecilia Täkte joins Cambio's leadership team as the Chief Commercial Officer. Cecilia’s recent experience makes her the perfect ch... |
31.08.2023 | Sanolium AB interim report April - June 2023 | Sanolium AB interim report April - June 2023
Thu, Aug 31, 2023 09:00 CET Report this content
Revenue in the second quarter amounted to 273.0 MSEK, representing a growth of 24.4%
CEO´s comment
Cambio continues to take steps on the journey to... |
31.05.2023 | Sanolium AB interim report, January - March 2022 | Sanolium AB interim report, January - March 2022
Wed, May 31, 2023 09:00 CET Report this content
CEO’s Comments
Growing demand for our solutions reflects the need for increased digitalization in health and social
care. The Nordic regions an... |
28.02.2023 | Sanolium interim report Q4 oct-dec 2022 | Sanolium interim report Q4 oct-dec 2022
Tue, Feb 28, 2023 09:00 CET Report this content
Cambio is well positioned to become the Nordic leader within eHealth. Today we serve Nordic regions, municipalities, and private healthcare provi-ders b... |
30.11.2022 | Sanolium AB interim report, July – September 2022 | Sanolium AB interim report, July – September 2022
Wed, Nov 30, 2022 09:00 CET Report this content
Cambio constitutes the operating entities under Sanolium AB. All figures in () refer to the comparable figures from previous year. Full-year 2... |
31.10.2022 | Cambio strengthens position as market leader by acquiring FRISQ AB | Cambio strengthens position as market leader by acquiring FRISQ AB
Mon, Oct 31, 2022 20:45 CET Report this content
Cambio has a market leading position on the Swedish ehealth market and are now furter expanding their offer by acquiering FRI... |
19.08.2022 | Sanolium AB interim report, April – June 2022 | Sanolium AB interim report, April – June 2022
Fri, Aug 19, 2022 08:30 CET Report this content
Revenue in the second quarter amounted to 219.5 (195.8) MSEK, representing an increase of 12.1%. Support and maintenance fees constitute the large... |
21.07.2022 | Cambio and FRISQ enters into a formal exclusive process to divest FRISQ to Cambio with a target transaction date in September 2022 | Cambio and FRISQ enters into a formal exclusive process to divest FRISQ to Cambio with a target transaction date in September 2022
Thu, Jul 21, 2022 08:00 CET Report this content
FRISQ board has decided to enter into a formal exclusive proc... |
22.06.2022 | Cambio and Worldish sign a partnership to solve communication barriers in healthcare and municipal care | The collaboration will promote improvements in the quality of care and make healthcare accessible to those with language and / or functional disabilities.
STOCKHOLM, STOCKHOLM, SWEDEN, June 22, 2022 /EINPresswire.com/ -- Cambio is a leading... |
31.05.2022 | Sanolium AB interim report, January - March 2022 | Sanolium AB interim report, January - March 2022
Tue, May 31, 2022 13:45 CET Report this content
Revenue in the first quarter amounted to 205.3 (206.7) MSEK, representing a decrease of -0.7%
Revenue in the first quarter amounted to 205.3 (2... |
06.05.2022 | Johannes Fabó new Chief Financial Officer at Cambio | Johannes Fabó new Chief Financial Officer at Cambio
Fri, May 06, 2022 09:00 CET Report this content
Cambio has appointed Johannes Fabó as Chief Financial Officer. Johannes, who will join Cambio effective 15th of August 2022, will also be a ... |
18.02.2022 | Sanolium Interim report 4/2021 | Sanolium Interim report 4/2021
Fri, Feb 18, 2022 09:00 CET Report this content
Revenues in the fourth quarter amounted to 196.6 MSEK, representing growth of 17.6%
Support and maintenance fees constitute the largest share of the revenue. Lic... |
30.11.2021 | Sanolium AB interim report, July - September 2021 | Sanolium AB interim report, July - September 2021 Tue, Nov 30, 2021 16:48 CET
Q3, July - September 2021
Revenue amounted to 191.4 (158.5) MSEK in the third quarter, representing a growth of 20.8%
Adjusted EBITDA amounted to 75.4 (43.7) MSEK... |
04.10.2021 | Sanolium AB announces Rami Avidan as new CEO | Sanolium AB announces Rami Avidan as new CEO Mon, Oct 04, 2021 09:00 CET
Stockholm, 4th of October 2021 Sanolium AB’s Board of, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, today announces that its Board of Dir... |
19.08.2021 | Revenue in the second quarter amounted to 195.8 MSEK, representing growth of 7.3% | Revenue in the second quarter amounted to 195.8 MSEK, representing growth of 7.3% Thu, Aug 19, 2021 11:00 CET
Revenue in the second quarter amounted to 195.8 (182.4) MSEK, representing a growth of 7.3%. Support and maintenance fees constitu... |
31.05.2021 | Sanolium AB interim report, January - March 2021 | Sanolium AB interim report, January - March 2021 Mon, May 31, 2021 11:09 CET
Revenue amounted to 206.7(177.9) MSEK in the first quarter, representing a growth of 16.2%. Adjusted EBITDA amounted to 52.3(49.6)MSEK, representing a growth of 5.... |